{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:37:05Z","timestamp":1793731025370,"version":"4.6.1"},"reference-count":50,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chronic myeloid leukemia in chronic phase (CML-CP) is induced by BCR-ABL1 oncogenic tyrosine kinase. Tyrosine kinase inhibitors eliminate the bulk of CML-CP cells, but fail to eradicate leukemia stem cells (LSCs) and leukemia progenitor cells (LPCs) displaying innate and acquired resistance, respectively. These cells may accumulate genomic instability, leading to disease relapse and\/or malignant progression to a fatal blast phase. In the present study, we show that Rac2 GTPase alters mitochondrial membrane potential and electron flow through the mitochondrial respiratory chain complex III (MRC-cIII), thereby generating high levels of reactive oxygen species (ROS) in CML-CP LSCs and primitive LPCs. MRC-cIII\u2013generated ROS promote oxidative DNA damage to trigger genomic instability, resulting in an accumulation of chromosomal aberrations and tyrosine kinase inhibitor\u2013resistant BCR-ABL1 mutants. JAK2(V617F) and FLT3(ITD)\u2013positive polycythemia vera cells and acute myeloid leukemia cells also produce ROS via MRC-cIII. In the present study, inhibition of Rac2 by genetic deletion or a small-molecule inhibitor and down-regulation of mitochondrial ROS by disruption of MRC-cIII, expression of mitochondria-targeted catalase, or addition of ROS-scavenging mitochondria-targeted peptide aptamer reduced genomic instability. We postulate that the Rac2-MRC-cIII pathway triggers ROS-mediated genomic instability in LSCs and primitive LPCs, which could be targeted to prevent the relapse and malignant progression of CML.<\/jats:p>","DOI":"10.1182\/blood-2011-10-385658","type":"journal-article","created":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T04:59:50Z","timestamp":1331614790000},"page":"4253-4263","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":177,"title":["Rac2-MRC-cIII\u2013generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors"],"prefix":"10.1182","volume":"119","author":[{"given":"Margaret","family":"Nieborowska-Skorska","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr K.","family":"Kopinski","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Hoser","sequence":"additional","affiliation":[{"name":"Department of Clinical Cytology, Medical Center for Postgraduate Education, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Ngaba","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Flis","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Cramer","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamatha M.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Koptyra","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyrone","family":"Penserga","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Glodkowska-Mrowka","sequence":"additional","affiliation":[{"name":"Department of Immunology, Medical University of Warsaw, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bolton","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa L.","family":"Holyoake","sequence":"additional","affiliation":[{"name":"Paul O'Gorman Leukemia Research Centre, University of Glasgow, Glasgow, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie J.","family":"Eaves","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Cerny-Reiterer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna and Ludwig-Boltzmann Oncology Cluster, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna and Ludwig-Boltzmann Oncology Cluster, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Jena University Hospital, Jena, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Hematology and Centre for Cancer Biology, University of Adelaide School of Medicine, Adelaide, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"van der Kuip","sequence":"additional","affiliation":[{"name":"Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sattler","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieslaw","family":"Wiktor-Jedrzejczak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Biology and Center of Bioinformatics, University of North Carolina at Charlotte, Charlotte, NC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Dorrance","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Children's Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard Stem Cell Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Stoklosa","sequence":"additional","affiliation":[{"name":"Department of Immunology, Medical University of Warsaw, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Children's Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard Stem Cell Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Skorski","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2020071614030630600_B1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"2020071614030630600_B2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer.","volume":"7","author":"Melo","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2020071614030630600_B3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"issue":"7","key":"2020071614030630600_B4","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: mechanisms of blastic transformation.","volume":"120","author":"Perrotti","year":"2010","journal-title":"J Clin Invest"},{"issue":"1-2","key":"2020071614030630600_B5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.mrfmmm.2003.06.002","article-title":"The interacting pathways for prevention and repair of oxidative DNA damage.","volume":"531","author":"Slupphaug","year":"2003","journal-title":"Mutat Res"},{"issue":"6","key":"2020071614030630600_B6","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","article-title":"Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.","volume":"111","author":"Sallmyr","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2020071614030630600_B7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","article-title":"BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance.","volume":"108","author":"Koptyra","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2020071614030630600_B8","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2004-05-1941","article-title":"BCR\/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks.","volume":"104","author":"Nowicki","year":"2004","journal-title":"Blood"},{"issue":"26","key":"2020071614030630600_B9","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.1074\/jbc.M600064200","article-title":"Activated Jak2 with the V617F point mutation promotes G1\/S phase transition.","volume":"281","author":"Walz","year":"2006","journal-title":"J Biol Chem"},{"issue":"6","key":"2020071614030630600_B10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1097-2765(04)00124-8","article-title":"Respiratory complex III is required to maintain complex I in mammalian mitochondria.","volume":"13","author":"Ac\u00edn-P\u00e9rez","year":"2004","journal-title":"Mol Cell"},{"issue":"2","key":"2020071614030630600_B11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2008.06.017","article-title":"Superoxide flashes in single mitochondria.","volume":"134","author":"Wang","year":"2008","journal-title":"Cell"},{"issue":"20","key":"2020071614030630600_B12","doi-asserted-by":"crossref","first-page":"11858","DOI":"10.1073\/pnas.95.20.11858","article-title":"BCR\/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac.","volume":"95","author":"Skorski","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"97","key":"2020071614030630600_B13","doi-asserted-by":"crossref","first-page":"ra73","DOI":"10.1126\/scisignal.2000431","article-title":"Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.","volume":"2","author":"Hitosugi","year":"2009","journal-title":"Sci Signal"},{"issue":"10","key":"2020071614030630600_B14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/leu.2008.78","article-title":"BCR\/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress.","volume":"22","author":"Koptyra","year":"2008","journal-title":"Leukemia"},{"issue":"4929","key":"2020071614030630600_B15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.2814477","article-title":"Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation.","volume":"246","author":"King","year":"1989","journal-title":"Science"},{"key":"2020071614030630600_B16","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1097\/CCM.0b013e31818a8a51","article-title":"Early mitochondrial dysfunction in electron transfer activity and reactive oxygen species generation after cardiac arrest.","volume":"36","author":"Han","year":"2008","journal-title":"Crit Care Med"},{"issue":"3","key":"2020071614030630600_B17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1172\/JCI37048","article-title":"Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans.","volume":"119","author":"Anderson","year":"2009","journal-title":"J Clin Invest"},{"issue":"9","key":"2020071614030630600_B18","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1182\/blood.V98.9.2808","article-title":"Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571.","volume":"98","author":"Wolff","year":"2001","journal-title":"Blood"},{"issue":"3","key":"2020071614030630600_B19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/0008-5472.CAN-10-1066","article-title":"BCR\/ABL stimulates WRN to promote survival and genomic instability.","volume":"71","author":"Slupianek","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"2020071614030630600_B20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0027-5107(73)90265-0","article-title":"A table for the estimation of the spontaneous mutation rate of cells in culture.","volume":"17","author":"Capizzi","year":"1973","journal-title":"Mutat Res"},{"issue":"11","key":"2020071614030630600_B21","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia.","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"2020071614030630600_B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","article-title":"Free radicals, metals and antioxidants in oxidative stress-induced cancer.","volume":"160","author":"Valko","year":"2006","journal-title":"Chem Biol Interact"},{"issue":"9","key":"2020071614030630600_B23","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","article-title":"Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1.","volume":"88","author":"Smiley","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 6","key":"2020071614030630600_B24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1042\/bst0311295","article-title":"Using mitochondria-targeted molecules to study mitochondrial radical production and its consequences.","volume":"31","author":"Smith","year":"2003","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2020071614030630600_B25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.resp.2007.01.016","article-title":"Chemoreception in the context of the general biology of ROS.","volume":"157","author":"Gonzalez","year":"2007","journal-title":"Respir Physiol Neurobiol"},{"issue":"2","key":"2020071614030630600_B26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1083\/jcb.200111028","article-title":"Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases.","volume":"158","author":"Werner","year":"2002","journal-title":"J Cell Biol"},{"issue":"49","key":"2020071614030630600_B27","doi-asserted-by":"crossref","first-page":"35666","DOI":"10.1074\/jbc.M703571200","article-title":"Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases.","volume":"282","author":"Shutes","year":"2007","journal-title":"J Biol Chem"},{"issue":"20","key":"2020071614030630600_B28","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1073\/pnas.0307512101","article-title":"Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.","volume":"101","author":"Gao","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3-4","key":"2020071614030630600_B29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1155\/2010\/380291","article-title":"Rac GTPases in human diseases.","volume":"29","author":"Pai","year":"2010","journal-title":"Dis Markers"},{"issue":"5730","key":"2020071614030630600_B30","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1126\/science.1106653","article-title":"Extension of murine life span by overexpression of catalase targeted to mitochondria.","volume":"308","author":"Schriner","year":"2005","journal-title":"Science"},{"issue":"3","key":"2020071614030630600_B31","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bbrc.2004.08.169","article-title":"Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia.","volume":"323","author":"Sorel","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2020071614030630600_B32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrc799","article-title":"Oncogenic tyrosine kinases and the DNA-damage response.","volume":"2","author":"Skorski","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"7281","key":"2020071614030630600_B33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"issue":"20","key":"2020071614030630600_B34","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment.","volume":"118","author":"Chu","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2020071614030630600_B35","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1074\/jbc.273.11.6297","article-title":"Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha.","volume":"273","author":"Kang","year":"1998","journal-title":"J Biol Chem"},{"issue":"7","key":"2020071614030630600_B36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"2020071614030630600_B37","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/1535-7163.MCT-07-0553","article-title":"Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells.","volume":"7","author":"Samudio","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2020071614030630600_B38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2020071614030630600_B39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1113\/expphysiol.2006.033506","article-title":"Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia.","volume":"91","author":"Guzy","year":"2006","journal-title":"Exp Physiol"},{"issue":"20","key":"2020071614030630600_B40","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/sj.onc.1208461","article-title":"Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation.","volume":"24","author":"Barnes","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"2020071614030630600_B41","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1182\/blood.V91.5.1700","article-title":"Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3.","volume":"91","author":"Amarante-Mendes","year":"1998","journal-title":"Blood"},{"issue":"7","key":"2020071614030630600_B42","doi-asserted-by":"crossref","first-page":"e21924","DOI":"10.1371\/journal.pone.0021924","article-title":"Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells.","volume":"6","author":"Kluza","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"2020071614030630600_B43","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species.","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2020071614030630600_B44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-5793(03)00454-X","article-title":"Phosphoinositide 3-kinase-dependent activation of Rac.","volume":"546","author":"Welch","year":"2003","journal-title":"FEBS Lett"},{"issue":"41","key":"2020071614030630600_B45","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/sj.onc.1206626","article-title":"Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl.","volume":"22","author":"Harnois","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"2020071614030630600_B46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccr.2007.10.015","article-title":"Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease.","volume":"12","author":"Thomas","year":"2007","journal-title":"Cancer Cell"},{"issue":"1","key":"2020071614030630600_B47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood-2009-10-247437","article-title":"Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo.","volume":"116","author":"Sengupta","year":"2010","journal-title":"Blood"},{"issue":"23","key":"2020071614030630600_B48","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1158\/0008-5472.CAN-08-1131","article-title":"Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.","volume":"68","author":"Konig","year":"2008","journal-title":"Cancer Res"},{"issue":"9","key":"2020071614030630600_B49","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djk150","article-title":"Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.","volume":"99","author":"Jiang","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2020071614030630600_B50","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/leu.2009.222","article-title":"Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment.","volume":"24","author":"Haferlach","year":"2010","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/18\/4253\/1352245\/zh801812004253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/18\/4253\/1352245\/zh801812004253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:17:04Z","timestamp":1594948624000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/18\/4253\/30064\/Rac2MRCcIIIgenerated-ROS-cause-genomic-instability"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,3]]},"references-count":50,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,5,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-10-385658","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,3]]}}}